Sian Fereday Selected Research

Sian Fereday Research Topics

19	Ovarian Neoplasms (Ovarian Cancer) 01/2021 - 08/2008
16	Neoplasms (Cancer) 01/2021 - 08/2008
12	Carcinoma (Carcinomatosis) 01/2020 - 02/2009
3	Ovarian Epithelial Carcinoma 01/2020 - 01/2018
2	Melanoma (Melanoma, Malignant) 01/2021 - 01/2019
2	Residual Neoplasm 01/2020 - 09/2008
2	Endometrioid Carcinoma 08/2013 - 10/2010
1	Endometriosis 01/2022
1	Inflammation (Inflammations) 01/2022
1	Pelvic Inflammatory Disease (Pelvic Inflammatory Diseases) 01/2022
1	Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal) 01/2022
1	Nevus (Nevi) 01/2021
1	Turcot syndrome 01/2020
1	Breast Neoplasms (Breast Cancer) 01/2019
1	Sarcoma (Soft Tissue Sarcoma) 11/2018
1	Obesity 04/2014
1	Overweight 04/2014

5	Biomarkers (Surrogate Marker)IBA 01/2021 - 08/2013
4	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 02/2009
4	PlatinumIBA 01/2019 - 02/2009
4	Proteins (Proteins, Gene)FDA Link 10/2018 - 02/2009
3	Carboplatin (JM8)FDA LinkGeneric 01/2021 - 09/2008
2	Hormones (Hormone)IBA 01/2022 - 08/2013
2	Pharmaceutical PreparationsIBA 01/2022 - 01/2019
2	MicroRNAs (MicroRNA)IBA 01/2021 - 01/2019
2	Biological ProductsIBA 01/2021 - 08/2008
2	ChromatinIBA 01/2021 - 12/2016
2	Paclitaxel (Taxol)FDA LinkGeneric 01/2019 - 09/2008
2	taxaneIBA 01/2018 - 09/2008
2	Poly(ADP-ribose) Polymerase InhibitorsIBA 04/2017 - 07/2012
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2022
1	Talc FDA Link 01/2022
1	SmokeIBA 01/2022
1	RNA (Ribonucleic Acid)IBA 01/2021
1	Small Cytoplasmic RNAIBA 01/2021
1	Formaldehyde (Formol)FDA Link 01/2021
1	ParaffinIBA 01/2021
1	Androgen Receptors (Androgen Receptor)IBA 01/2020
1	Progesterone Receptors (Progesterone Receptor)IBA 01/2020
1	Messenger RNA (mRNA)IBA 01/2019
1	CA-125 Antigen (CA 125 Antigen)IBA 11/2018
1	dabrafenibIBA 11/2018
1	Mitogen-Activated Protein KinasesIBA 11/2018
1	Toll-Like Receptor 4IBA 01/2018
1	TransducinIBA 01/2018
1	Retinoblastoma ProteinIBA 01/2018
1	Circulating Tumor DNAIBA 04/2017
1	Cell-Free Nucleic AcidsIBA 04/2017
1	Ligases (Synthetase)IBA 12/2016
1	UbiquitinIBA 12/2016
1	Indicators and Reagents (Reagents)IBA 12/2014
1	liposomal doxorubicin (Doxil)FDA Link 08/2012
1	OligonucleotidesIBA 02/2009
1	Cadherins (E-Cadherin)IBA 08/2008
1	Differentiation AntigensIBA 08/2008

12	Drug Therapy (Chemotherapy) 01/2021 - 09/2008
6	Therapeutics 01/2022 - 01/2013
1	Aftercare (After-Treatment) 01/2018
1	Neoadjuvant Therapy 09/2016
1	Combination Drug Therapy (Combination Chemotherapy) 05/2015